192 related articles for article (PubMed ID: 30318453)
21. Estimation of cholesterol loading of the low-density lipoprotein fraction in diabetic subjects without ultracentrifugation.
Yoshino G; Iwai M; Matsuba K; Iwatani I; Matsushita M; Kazumi T; Baba S
Diabetes Res Clin Pract; 1989 Aug; 7(2):155-7. PubMed ID: 2776655
[TBL] [Abstract][Full Text] [Related]
22. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
23. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects.
Cohn JS; Tremblay M; Amiot M; Bouthillier D; Roy M; Genest J; Davignon J
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):149-59. PubMed ID: 8548416
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of chylomicrons in subjects with dysbetalipoproteinaemia (type III hyperlipoproteinaemia).
Haffner SM; Kushwaha RS; Hazzard WR
Eur J Clin Invest; 1989 Oct; 19(5):486-90. PubMed ID: 2511026
[TBL] [Abstract][Full Text] [Related]
25. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM
Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
Evans AJ; Huff MW; Wolfe BM
J Lipid Res; 1989 Nov; 30(11):1691-701. PubMed ID: 2614271
[TBL] [Abstract][Full Text] [Related]
27. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
[TBL] [Abstract][Full Text] [Related]
28. A simplified diagnosis algorithm for dysbetalipoproteinemia.
Paquette M; Bernard S; Blank D; Paré G; Baass A
J Clin Lipidol; 2020; 14(4):431-437. PubMed ID: 32631794
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
30. Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia.
Luc G; de Gennes JL; Chapman MJ
Atherosclerosis; 1988 Jun; 71(2-3):143-56. PubMed ID: 3401287
[TBL] [Abstract][Full Text] [Related]
31. Lipoproteins in familial dysbetalipoproteinemia. Variation of serum cholesterol level associated with VLDL concentration.
Zhao SP; Smelt AH; Leuven JA; van den Maagdenberg AM; van der Laarse A; van 't Hooft FM
Arterioscler Thromb; 1993 Feb; 13(2):316-23. PubMed ID: 8427867
[TBL] [Abstract][Full Text] [Related]
32. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis.
Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675
[TBL] [Abstract][Full Text] [Related]
34. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol in the plasma very low density lipoprotein fraction in patients with type III hyperlipoproteinemia: analysis of factors which modulate its concentration.
Sutherland WH; Janus ED; Nye ER; Grant S
Biochem Med Metab Biol; 1988 Jun; 39(3):305-11. PubMed ID: 3165001
[TBL] [Abstract][Full Text] [Related]
36. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels.
Alaupovic P; Heinonen T; Shurzinske L; Black DM
Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.
Civeira F; Cenarro A; Ferrando J; Puzo J; Garcia-Otín AL; Mozas P; Pocoví M
Am Heart J; 1999 Jul; 138(1 Pt 1):156-62. PubMed ID: 10385780
[TBL] [Abstract][Full Text] [Related]
39. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
40. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
